SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
B.1.617 is becoming a dominant Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) lineage worldwide with many sublineages, of which B.1.617.2 is designated as a variant of concern. The pathogenicity of B.1.617.2 (Delta) and B.1.617.3 lineage of SARS-CoV-2 was evaluated and compared with that of B.1, an early virus isolate with D614G mutation in a Syrian hamster model. Viral load, antibody response, and lung disease were studied. There was no significant difference in the virus shedding pattern among these variants. High levels of SARS-CoV-2 sub genomic RNA were detected in the respiratory tract of hamsters infected with the Delta variant for 14 days, which warrants further transmission studies. The Delta variant induced lung disease of moderate severity in about 40% of infected animals, which supports the attributed disease severity of the variant. Cross neutralizing antibodies were detected in animals infected with B.1, Delta, and B.1.617.3 variant, but neutralizing capacity was significantly lower with B.1.351 (Beta variant).
Article activity feed
-
-
SciScore for 10.1101/2021.07.24.453631: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics Euthanasia Agents: Six hamsters each were challenged with 0.1 ml of 105 TCID50/ml of B.1/Delta/B.1.617.3 virus variants intranasally under isoflurane anesthesia. Sex as a biological variable Animal experiments: For the virus shedding study, eighteen female, Syrian hamsters of 8-10-week-old age were divided into 3 groups of 6 animals each. Randomization not detected. Blinding The lesions were graded on a numerical scale from 0 to 4 as no abnormality (0), minimal (1), mild (2), moderate (3) and severe (4) based on the severity of lesions observed by blinded scoring. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Anti-SARS-CoV-2 antibody … SciScore for 10.1101/2021.07.24.453631: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics Euthanasia Agents: Six hamsters each were challenged with 0.1 ml of 105 TCID50/ml of B.1/Delta/B.1.617.3 virus variants intranasally under isoflurane anesthesia. Sex as a biological variable Animal experiments: For the virus shedding study, eighteen female, Syrian hamsters of 8-10-week-old age were divided into 3 groups of 6 animals each. Randomization not detected. Blinding The lesions were graded on a numerical scale from 0 to 4 as no abnormality (0), minimal (1), mild (2), moderate (3) and severe (4) based on the severity of lesions observed by blinded scoring. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Anti-SARS-CoV-2 antibody detection: The serum samples collected on day 3, 5, 7 and 14 DPI were tested for IgG antibodies by a hamster anti-SARS-CoV-2 IgG ELISA as described earlier [15]. Anti-SARS-CoV-2suggested: NoneIgGsuggested: Noneanti-SARS-CoV-2 IgGsuggested: NoneExperimental Models: Cell Lines Sentences Resources The isolates were propagated and passage twice in VeroCCL81 cells and sequence verified by Next generation sequencing. VeroCCL81suggested: NoneSoftware and Algorithms Sentences Resources Statistical analysis: The data collected from the study was analysed using Graph pad Prism version 8.4.3. Graph pad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-
-